Get started
Author

Otávio Baiocchi

Observed names: Baiocchi, Otavio C. G., O Baiocchi, O. Baiocchi, O.C.C.G. Baiocchi, O.C.G. Baiocchi, Otavio Baiocchi, Otavio C. Baiocchi, Otavio C.C.G. Baiocchi, Otavio Cesar Carvalho Guimarães Baiocchi, Otávio Cesar Carvalho Guimarães Baiocchi, Otávio C. Baiocchi, Otávio Cesar Carvalho Guimaraes Baiocchi, Otávio Cesar Carvalho Guimarães Baiocchi, Otávio César Carvalho Guimarães Baiocchi
Observed institutions: University of Notre Dame, Santa Paula Hospital, Hospital Santa Paula, Hospital Alemão Oswaldo Cruz, Hospital Sírio-Libanês, Hospital São Paulo, General Hospital Dr. Josip Benčević Slavonski Brod, Universidade Federal de São Paulo
OpenAlex ID: A5109328142
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
2020 · Guilherme Fleury Perini, Thais Fischer, et al. · Hematology Transfusion and Cell Therapy · 36
PDF
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry
2017 · Irene Biasoli, Nelson Castro, et al. · International Journal of Cancer · 31
PDF
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry
2017 · Irene Biasoli, Nelson Castro, et al. · Hematological Oncology · 24
Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma
2008 · Leina Etto, Emílio Lacerda, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis
2024 · Rafael Amorim Belo Nunes, Álvaro Avezum, et al. · Annals of Hematology · 12
Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy
2019 · Marcelo Sato‐Sano, Solange Pistori Teixeira, et al. · The Journal of Dermatology · 9
Primary Effusion Lymphoma: A Rare and Challenging Diagnosis for Recurrent Pleural Effusion
2023 · Letícia Jacome Pereira, Sara Mohrbacher, et al. · Diagnostics · 7
PDF
Aconselhamento telefônico: identificação de sintomas em pacientes com linfoma em quimioterapia antineoplásica
2018 · Keilla Regina Santos Louzada, Maria Meimei Brevidelli, et al. · Acta Paulista de Enfermagem · 7
PDF
Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
2018 · Juliano Júlio Cerci, Mateos Bogoni, et al. · Hematology Transfusion and Cell Therapy · 6
Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
2023 · Irene Biasoli, Nelson Castro, et al. · eJHaem · 5
External validation and calibration of the HoLISTIC Consortium's advanced‐stage Hodgkin lymphoma international prognostic index (A‐ HIPI ) in the Brazilian Hodgkin lymphoma registry
2024 · Valeria Buccheri, Frederico Rafael Moreira, et al. · British Journal of Haematology · 4
PDF
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
2023 · Lilian Goveia, Nelson Castro, et al. · Annals of Hematology · 4
Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients
2023 · Julia Mota Leite, Tomás Zecchini Barrese, et al. · Annals of Hematology · 3
Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers’ Training in Brazil
2016 · Cristiane Decat Bergerot, Errol J. Philip, et al. · Journal of Global Oncology · 3
Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability
2023 · Flávia Dias Xavier, Danielle Leão Cordeiro de Farias, et al. · Oncotarget · 2
PDF
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
2021 · Alvaro J. Alencar, Alexandre V. Hirayama, et al. · Hematology Transfusion and Cell Therapy · 2
PDF
Regulatory CD 4+ T lymphocytes after allogeneic transfusion in orthopaedic surgical patients
2016 · Luciana A. Pereira, Otavio C. Baiocchi, et al. · British Journal of Haematology · 2
External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry
2023 · Irene Biasoli, Valeria Buccheri, et al. · Blood · 1
Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report
2021 · Karin Zattar Cecyn, Mariana Oliveira Marques, et al. · Blood Research · 1
PDF
Idiopathic Thrombocytopenic Purpura Related to COVID-19
2020 · Mariana M. Langhi, Andre N.R. Abdo, et al. · Journal of Medical Cases · 1
PDF
Lower Socioeconomic Status Is Associated With Shorter Survival in Hl Patients - an Analysis From the Brazilian Hodgkin Lymphoma Registry
2016 · Irène Biasoli, Nelson Castro, et al. · UNESP Institutional Repository (São Paulo State University) · 1
Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+
2004 · Celso M. Massumoto, Ronald F. Pinheiro, et al. · Revista Brasileira de Hematologia e Hemoterapia · 1
PDF
A rare case of fatal hepatic veno-occlusive disease and rupture of the spleen vein and artery after Gemtuzumab Ozogamicin (Mylotarg®) infusion
2004 · Celso M. Massumoto, Ronald F. Pinheiro, et al. · Revista Brasileira de Hematologia e Hemoterapia · 1
PDF
A structured approach for treatment selection in chronic lymphocytic leukemia: a multiregional expert consensus
2026 · Guilherme Fleury Perini, Ahmad Alhuraiji, et al. · Blood Global Hematology
PDF
An international view on the current approaches to frontline chronic lymphocytic leukemia therapy
2025 · Guilherme Perini, Ahmad Alhuraiji, et al. · Blood
PDF
Works count: 49
Citation count: 176
H-index: 7
I10-index: 5
Year
Topic
Type